Company page

Evolutionary Genomics, Inc.

Evolutionary Genomics, Inc. is a public company traded under the ticker FNAM in the American market. With a market capitalization of approximately $1.33 billion, the company focuses on advancements in genomic technologies. Its innovative approach aims to contribute to the field of genomics and biotechnology.